Nucleosyn
  • Home
  • Products
    • All products
    • Products categories
    • DNA-RNA
    • Synthetic lipids
    • Stable isotope
    • Custom chemical synthesis
  • Capabilities
  • About Us
  • Contact
  • Linkedin

My selection

Synthetic lipids

NucleoSyn produces and supplies synthetic lipids from milligrams to multi-kilos quantities.

Dlin-KC2-DMA

CAS #
1190197-97-7
Packing size
100 mg, 500 mg, 1 g, bulk (gram scale)
DLinsiRNA deliveryNanoparticleLNPLiposomeTransfectionCationic lipid
Dlin-KC2-DMA Image 1

DLin-KC2-DMA and Dlin-KC3-DMA exhibited in vivo activity at siRNA doses as low as 0.6mg/kg and 0,01mg/kg respectively in rodents. DLin-KC2-DMA produces significant siRNA-mediated gene silencing of GAPDH, when binds to lipid nanoparticles (LNPs).

Aspect
Yellowish oil
Purity
98%
Solubility
DMSO, EtOH
Molecular weight
642,11
Molecular formula

C43H79NO2

IUPAC
2-(2,2-di((9Z,12Z)-octadeca-9,12-dien-1-yl)-1,3-dioxolan-4-yl)-N,N-dimethylethan-1-amine

N. M. Belliveau et al., Molecular Therapy-Nucleic Acids, 2012, 1, e37/1-e37/9. read article

J. A. Kulkarni et al., ACS Nano, 2018, 12, 5, 4787–4795. read article

M. Jayaraman et al., Angew. Chem. Int. Ed. Engl., 2012, 51, 34, 8529-8533. read article

Purchase Dlin-KC2-DMA

Get a quote on this product

We're ready to solve any rare chemicals sourcing or molecular design problem... Give us a shout! Please fill out this form completely.

If you don't find a product in our current offer, please don't hesitate to request a quote using our contact form.

Add to my selection

Related products

[13C6]-Glucosylsphingosine ([13C6]-GlSph...
CAS #
299172-48-8
Details
[D5]-Phosphatidylethanol / [d5] - PEth a...
CAS #
1612140-92-7
Details
Glucosylsphingosine / (GlSph)
CAS #
52050-17-6
Details
See more products

logo footerNucleosyn

111 Bd Duhamel du Monceau

45160 Olivet

Products

See Catalog

Know more about products

Contact

Contact Form

+33 2 38 49 45 73

Follow us

Other Infos

Legal notices

Privacy Policy & cookies infos

General terms & conditions

© Nucleosyn 2025 - All rights reserved

Design and development Think Ad Communication